3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, MA; Booth, JWR; Menzies, RI; Mullins, JJ; Norman, JT; Tam, FWK; Unwin, RJ | 1 |
| Araujo, SR; Bergamaschi, CT; Buri, MV; Curi, MV; Fernandes, MJ; Ferreira, AT; Higa, EM; Maciel, FR; Nogueira, GB; Paredes-Gamero, EJ; Punaro, GR; Rodrigues, AM | 1 |
2 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Hyperglycemia-induced Renal P2X7 Receptor Activation Enhances Diabetes-related Injury.
Topics: Adenosine Triphosphate; Animals; Cells, Cultured; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Hyperglycemia; Kidney; Macrophages; Male; Mesangial Cells; Mice, Inbred C57BL; Mice, Knockout; Purinergic P2X Receptor Antagonists; Pyridines; Rats, Wistar; Receptors, Purinergic P2X7; Tetrazoles | 2017 |
P2X(7) receptor in the kidneys of diabetic rats submitted to aerobic training or to N-acetylcysteine supplementation [corrected].
Topics: Acetylcysteine; Adenosine Triphosphate; Administration, Oral; Albuminuria; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Exercise Therapy; Gene Expression; Kidney; Lipid Peroxidation; Male; Oxidative Stress; Physical Conditioning, Animal; Purinergic P2X Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P2X7; Streptozocin | 2014 |